Company has one year of cash to fund operations Company advancing plans to develop TPI 287, a novel, late stage abeotaxane ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback